Trial watch: an all-oral and interferon-free future for HCV therapy?

Nat Rev Drug Discov. 2011 Dec 1;10(12):891. doi: 10.1038/nrd3623.
No abstract available

Publication types

  • News

MeSH terms

  • Administration, Oral
  • Clinical Trials, Phase III as Topic / trends*
  • Forecasting
  • Hepatitis C / drug therapy*
  • Hepatitis C / enzymology
  • Humans
  • Interferons / administration & dosage
  • Nucleic Acid Synthesis Inhibitors / therapeutic use*
  • RNA-Dependent RNA Polymerase / antagonists & inhibitors
  • Sofosbuvir
  • Uridine Monophosphate / administration & dosage
  • Uridine Monophosphate / analogs & derivatives
  • Viral Nonstructural Proteins / antagonists & inhibitors

Substances

  • Nucleic Acid Synthesis Inhibitors
  • Viral Nonstructural Proteins
  • Interferons
  • Uridine Monophosphate
  • NS-5 protein, hepatitis C virus
  • RNA-Dependent RNA Polymerase
  • Sofosbuvir